Share price: Beximco Pharma overtakes Square for the first time

In terms of share price on Dhaka Stock Exchange (DSE), Beximco Pharmaceuticals has beaten market leader Square Pharmaceuticals, a development that has cheered up hundreds of investors who put their money on Beximco.

Square Pharma finished the day at Tk 243.8 per share while that of Beximco Pharma stood at Tk 247.40 on Tuesday. 

This is for the first time that the share price of Beximco Pharma exceeded that of Square Pharma, which is the leader with about one-sixth of the total market share.

And, this has happened at a time when Square Pharma is in the leading position in the pharmaceutical industry in terms of market share, PE ratio, profitability, market capitalisation, dividend yields, etc. Beximco Pharma is in the third position after Incepta.

But the ongoing coronavirus pandemic has paved the way for Beximco Pharma, which has attracted investors’ attention because of its 360-degree business, be it vaccines and diagnostic lab, centring the Covid-19 pandemic.

Beximco Pharma has also acquired Sanofi Bangladesh’s business after the French-based drug maker decided to pull out from the Bangladesh market.

Professional equity analysts cautioned investors in making their investments considering the quality of the stocks.